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One Decade “Narcotic Addicted Patients with Deep Vein Thrombosis” in 
St. Alzahra Hospital of Isfahan, Iran 
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Abstract 
Background: Behavior and substance addiction is one of the risk factors for deep vein thrombosis (DVT). The 
aim of this study investigating the relationship between the different clinical manifestations pattern of DVT 
with the way, the amount and duration of narcotic drugs in patients admitted to St. Alzahra Hospital in 
Isfahan, Iran, during 10 years. 
Methods: In a cross-sectional study we studied all of the patients with DVT in St. Alzahra Hospital since 
2003-2013 were studied. 
Findings: A total of 238 (59.1%) of the patients were male and 165 (40.9%) female. The mean age of men and 
women were 18.80 ± 48 and 19.60 ± 3.48 years old. The mean length of staying in the hospital was  
5.40 ± 7.20 days. Addiction among patients with DVT was 19.1%. 28.2% of men suffered from DVT and 6% of 
the women were drug addicts (P < 0.001). Among the 77 patients taking the drug, 53.2% were heroin, 
35.1%opium, and 11.7% used other injectable drugs. The results showed that 19 patients (28.6%) were taking 
the drug once daily, 27.3% twice a day, 6.5% three times a day, 15.6% once a week, and 26% taking the drug 
twice a week. From 403 patients, 2.2% had a problem in the upper limb, 44.4% in the left hand, and 55.6 in 
the right hand. The results showed that none of the 77 studied patients had involvement of upper limbs, but 
all of them in the lower limb. About 11.2% of studied patients were addicted to injective drugs. Also, 6% were 
addicted to non-injectable drugs and 2% to both injectable and non-injectable drugs. 
Conclusion: DVT has many risk factors and addiction and intravenously (IV) drug abuse one of the most 
important for this illness and this problem mast be noticed by health worker and physicians. 
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Introduction 
Deep vein thrombosis (DVT), is the creation of a 
blood clot (thrombus) in a deep vein, which may 
partially or completely block blood flow or be 
released and go to the lungs.1 DVT is a clinical 
challenge for physicians, which can complicate 
the pattern of a disease, but may also occur in the 
absence of other disorders. Thrombosis can occur 
in any part of the venous system, but often occurs 
in the deep veins of the lower limbs. The major 
concern is pulmonary embolism blood clots, 
which can be fatal.2 DVT is a relatively common 
disease with the annual incidence rate of 60-80 
cases per 100000 people for the first time in the 
U.S, and 3000000 new cases are identified every 
year.3,4 In the UK, around one in three new cases 
of DVT can be detected for every 1000 people.1 
Many cases of DVT are clinically silent and 
will recover on their own without complications. 
On the other hand, its clinical diagnosis is not 
accurate, so it is more difficult to determine its 
exact incidence time which is usually estimated 
less than the actual rate, but this rate is about 80 
cases per 100000 people each year in the general 
population. DVT primarily affects patients over 40 
years and is more common in men.5 Clinical 
manifestations of DVT depend on the degree of 
obstruction of venous flow, obstruction spot, and 
inflammation of the vessel wall. Patients may be 
asymptomatic but if it occurs, symptoms may 
include unilateral swelling of the affected limb 
with sensitivity, warmth, redness and swelling of 
superficial vessels. There is no relation between 
the sign and the size, location and extent of DVT.6 
DVT is more prevalent in users of drugs, 
especially injectable narcotics. At 3%, the annual 
incidence of DVT in drug addicts is about 100 
times higher than the general population.7-9 
In people who abuse drugs intravenously (IV), 
the degree of venous insufficiency or damaged 
blood vessels through injections, or through the 
formation of DVT develops. Long-term venous 
insufficiency can result in painful sores of the 
lower limb that can cause a negative impact on 
the quality-of-life.10 Besides, the risk of DVT 
incidence due to IV drug use is more prevalent in 
younger patients who are more likely to stay 
longer in hospital.11 There is debate on the cause 
of DVT in the general population, in which 
probabilities such as coagulation, stasis, vascular 
damage, and anoxia damage to venous valves are 
considered.12,13 However, the etiology factors are 
different among IV drug users. Possible causes 
include decreased blood flow from the inactive 
muscle pumps during intoxication, endothelial 
damage resulting from injection and high clotting 
factors due to infection infusion.14 Drug users 
with a history of DVT are reported to have poorer 
physical and mental health condition than users 
without a DVT history. This is consistent with 
long-term complications of DVT in the general 
population.2 
A common method of injecting drug users 
(IDU), which is common in some countries, is 
injecting into the femoral vein.15 Doctors assert 
that the such injection might increase the risk of 
DVT. However, the proportion of IDU in the 
development of DVT has received little attention. 
Drug abuse has increased in recent years, and IV 
addiction is the most common form of drug abuse 
in Iran. Previous studies have established a link 
between drug injection and DVT.16 According to 
available statistics, using drugs, either as injection 
or non-injection is increasing as one of the major 
risk factors for DVT in different social and age 
groups in developing countries such as Iran. In 
this regard, the pattern, amount, and duration of 
using are influential. As a result, this study made 
an attempt to carry out a retrospective study of 
the relationship between DVT and the pattern, 
amount and duration of using narcotic drugs in 
patients admitted to St. Alzahra Hospital in 
Isfahan, Iran, with this diagnosis from 2003-2013, 
and compare the effect the constant use of  
non-injectable and IV drugs injective with the use 
of non-injective narcotic drugs on DVT and finally 
investigate the impact of these issues on the 
pattern of different clinical and paraclinical 
manifestations of DVT. 
Methods 
This was a cross-sectional study carried out in St. 
Alzahra Medical Center in Isfahan in 2013. The 
population included all DVT patients who had 
been hospitalized. In this study, patients with DVT 
hospitalized in St. Alzahra Hospital in Isfahan 
during 2003-2013 were recalled, and questionnaires 
of using drugs were completed face-to-face so that 
drug-related information on the pattern, amount, 
and duration of non-injective and injective drugs 
use were collected and studied. 
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Inclusion criteria included: 
1. A history of hospitalization in St. Alzahra 
Hospital in Isfahan during the years of 2003-2013 
with the diagnosis of DVT and finding the file in 
the archives of Isfahan St. Alzahra Hospital 
2. The presence of the patient to complete the 
drug using questionnaire. 
Exclusion criteria included: 
1. Hospitalization in Isfahan St. Alzahra 
Hospital with the diagnosis of DVT in a time 
outside the outlined timeframe 
2. Insufficient information needed for patient 
records 
3. Absence of the patient to complete the drug 
using questionnaire. 
Systematic sampling was used in this study. 
The sample size was calculated using a sample 
size for prevalence studies mentioned below by 
considering a confidence level of 95%, 50% 
prevalence of drug use in patients with DVT and 
the significance level of 0.05 for 384 people. 
The data required for this study was provided 
by a questionnaire developed for this purpose, 
and they were completed by referring of the 
researcher to the patient’s file and contacting with 
the patient or his family. After the data had been 
collected, they were analyzed through SPSS 
software (version 18, SPSS Inc., Chicago, IL, USA) 
using chi-square, and t-test. 
Results 
In this study, 403 patients with DVT were studied 
from the beginning of 2003 to the end of 2013 
hospitalized in St. Alzahra Hospital. 238 (59.1%) 
of the patients were male, and 165 patients 
(40.9%) were female. The mean age of men and 
women were 18.8 ± 48 and 19.6 ± 48.8 years, 
respectively, and there was no significant 
difference between sexes (P = 0.900). 
25 (6.2%) of the patients under study were 
workers and farmers, 7 (1.7%) employees, 139 
(34.5%) were self-employed, 15 (3.7%) were school 
students and college students, 156 (38.7%) were 
housewives, and 61 (15.1%) were retired and 
unemployed. The mean length of hospital stay was 
5.4 ± 7.2 days. The minimum time of 
hospitalization was 1 days, and the maximum was 
70 days. The mean duration of hospitalization for 
men was 6.4 ± 7.5 and for women 3.3 ± 6.7 days, 
and there was no significant difference between 
sexes (P = 0.120). The results related to the 
prevalence of risk factors for DVT in patients under 
study are shown in figure 1. According to figure 1, 
the upper age the highest frequency in these 
patients (59.1%). 
According to the results, 41 patients (10.2%) 
did not have any risk factor. 185 patients (45.9%) 
had one risk factor, 131 patients (32.5%), had two 
risk factors, 37 (9.2%) had three risk factors, and 9 
patients (2.2%) had four risk factors. The most 
common risk factor was for people who had one 
risk factor and the least common risk factor was 
for people who had four risk factors.  
Based on the results obtained from 403 
 
 
Figure 1. Frequency of deep vein thrombosis risk factors in the studied patients 
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patients, 9 patients (2.2%) had problem in the 
upper limb, among which 4 patients (44.4%) had 
problem in the left hand, and 5 patients (55.6%) 
had problem in the right hand. Also, 394 patients 
(97.8%) had problem in the lower limb, among 
whom 242 patients (61.4%) had problem in the left 
leg, 139 (35.3%) had problem in the right leg, and 
13 (3.3%) had problem in both feet. On the other 
hand, 3 men and 6 women had problem in the 
upper limb (1.2% vs. 3.6%) and reciprocally, 235 
men and 159 women had lower extremity involve 
had problem in the lower limb (98.7 vs. 96.4%). 
However, Fisher’s exact test showed that the 
upper limb involvement does not have a 
significant difference (P = 0.190) in terms of 
gender, but involvement of the lower limb is 
different in the two sexes (P = 0.020). 
392 patients (97.3%) patients had swelling in 
the area, 344 (85.4%) had pain, 131 patients 
(32.5%) had sensitivity, 195 patients (48.4%) felt 
warmth in the area, 96 patients (23.8%) had 
redness, 6 patients (1.5%) had swollen region, and 
28 patients (7%) had fever as well. 
45 (11.2%) of studied patients were addicted 
to injective drugs. Furthermore, 24 patients 
(6.0%) were addicted to non-injectable drugs and 
8 patients (2.0%) were addicted to both injectable 
and non-injectable drugs. According to the 
figure, the prevalence of addiction among 
patients with DVT was 19.1%. According to this 
result, 28.2% of men suffered from DVT and 6% 
of the women were drug addicts and the  
chi-square test showed that the prevalence of 
addiction was significantly higher (P < 0.001) 
among male patients. Among the 77 patients 
taking the drug, 41 patients (3.2%) were heroin 
addicts, 27 patients (35.1%) were opium addicts 
and its derivatives (sap and burned), and 9 
patients (11.7%) used other injectable drugs such 
as norgesic and temgesic. 
The results showed that 19 patients (28.6%) 
were taking the drug once a day, 21 patients 
(27.3%) twice a day, 5 patients (6.5%) three times a 
day, 12 patients (15.6%) once a week, and 20 
patients (26.0%) were taking the drug twice a 
week. The results showed that none of the  
77 studied patients had involvement of upper 
limbs, but all of them had a problem in the lower 
limb. Furthermore, among the 41 patients taking 
the drug, only 28 patients had a problem in the 
left foot, had a problem in the right foot. Among 
the 27 taking opiates, only 14 patients had 
involvement in the left foot, and 13 patients had a 
problem in the right foot. Among the 9 patients 
using norgesic and temgesic, 4 had involvement 
in the left foot, and 5 patients had a problem in 
the right foot or both feet. Chi-square test showed 
that DVT clinical manifestations have a significant 
difference depending on the drug used  
(P = 0.002). 13 (54.2%) of those using drugs 
constantly had a problem in the left foot (54.2 vs. 
62.3%). Meanwhile, chi-square test showed that 
there is no relationship between the constant use 
of the drug and the part of body suffering from 
DVT (P = 0.430). 
Investigating the incidence pattern of DVT from 
2003-2013 
According to the investigations carried out, whose 
results are shown in table 1, the average annual 
incidence of DVT in St. Alzahra Hospital was 
about four thousand cases hospitalized from  
2003-2006. For example, in 2006, from a total of 
27443 patients admitted to the St. Alzahra 
Hospital, DVT 110 cases were found. Taking this 
into account, the prevalence of the disease among 
the hospitalized patients was 4000 in that year. 
The results of subsequent years are shown in  
table 1. However, the statistical analysis on the 
data showed that the incidence pattern of DVT 
has increased in the past decade. However, this 
trend was not statistically significant (P = 0.360). 
Figure 2 shows the variation pattern of DVT. 
 
Table 1. Distribution of DVT cases in St. Alzahra Hospital from 2003-2013 
Year Number of hospitalized patients DVT cases Prevalence (per 1000) 
2003-2006 27443 110 4 (The annual average) 
2007 34311 160 4.7 
2008 36603 133 3.6 
2009 40824 173 4.2 
2010 41334 187 4.5 
2011 41756 195 4.7 
2012 45010 200 4.4 
2013 44765 280 6.3 
DVT: Deep vein thrombosis 
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Increased prevalence of addiction during the 
past decade has certainly had a positive impact on 
the high incidence of DVT. Review of patients’ 
records from 2003-2013 showed that the 
prevalence of addiction has had an increasing 
trend until 2004 and then has declined for 2 years 
and later took a rising trend again in 2013.  
Chi-square test showed that the prevalence 
pattern of drug use among patients with DVT has 
had a significant difference during this period  
(P = 0.010). Results are shown in figure 3. 
Investigating the prevalence rate of DVT risk 
factors from 2003-2013 
Changes in the prevalence pattern of DVT risk 
factors over a period of 10 years are shown in 
figures 4 and 5. According to the two figures, 
most of the mentioned risk factors have had a 
changing trend during this period but the drug 
use and smoking risk factors have had an 
increasing trend in the whole period. 
Discussion 
The overall purpose of this study was to determine 
the relationship between the pattern of different 
clinical and paraclinical manifestations of DVT 
with DVT and the pattern, amount and duration of 
using narcotic drugs in patients hospitalized in St. 
Alzahra Hospital in Isfahan with this diagnosis 
from 2003-2013. The mean age of patients was 
approximately 48 years old which is consistent 
with the age range of people over age 40 who are 
considered susceptible to DVT. 
 
 
Figure 2. The prevalence of deep vein thrombosis among patients hospitalized in St. 
Alzahra Hospital from 2003-2013 
DVT: Deep vein thrombosis 
 
 
Figure 3. The prevalence pattern of drug abuse among patients with deep vein 
thrombosis from 2006-2013 
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Figure 4. Prevalence of deep vein thrombosis risk factors from 2006-2013 
 
 
Figure 5. Investigating the prevalence of deep vein thrombosis risk factors from 2006-2013 
DVT: Deep vein thrombosis; OCP: Oral contraceptive pill 
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et al., the mean age of patients was 47 years17 and 
also a study in the UK, the average age of patients 
with DVT was 62 years old.18 In the present study, 
around 60.0% of patients were male. According to 
previous studies, complications of DVT are more 
common in men,19-23 which is in line with the 
results of this study. In study by Masoomi et al. 
conducted in Kerman, Iran, from a total 150 
patient with DVT, 95 were males and 55 were 
females.16 
One key difference between the two sexes is 
possibly due to differences in exposure to risk 
factors causing the disease between the two sexes. 
For instance, inactivity in long trips is one of the 
most important DVT factors which is more 
occurring among men rather than women. In a 
study conducted Soleimanpour in Kermanshah, 
Iran, approximately 56.0% of patients with DVT 
were male.24 11.2% of patients were addicted to IV 
drugs and 6.0%, were addicted to non-injective 
drugs, and 2.0% were both addicted to injective 
and non-injective drugs. Methods of using drugs 
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venous injury due to injection or the DVT 
formation.10 For example, the role of IV cocaine, 
crack and heroin have been identified well for 
venous injuries.25 
The relationship DVT with IV drug abuse has 
been examined in previous studies.26,27 Ghosheh 
and Kahuria have reported one case of drug abuse 
with high venous thrombosis after direct injection 
of heroin.28 Drug addictions can raise the risk of 
DVT for several reasons which have been 
mentioned in several studies. First, injective drug 
addiction is one of the most important factors for 
the incidence of thrombosis in the veins and 
directly results in getting the disease by patients. 
On the other hand, drug addiction is an important 
factor for individual’s inactivity and addicts lose 
mobility due to physical dementia, and long 
inactivity provides the ground for the incidence of 
DVT in them. Long-term rests after drug use and 
also being drug sleepy and sluggish when they 
need drugs will cause the patient to lose its true 
mobility and provide the ground for the incidence 
of DVT. Masoomi et al. reported the risk of DVT 
in patients with IV drug suing to be 4.25 times 
more than others.16 
Another point that should be mentioned in this 
context is the use of materials and compounds 
that addicts use as a medicine or drug, but these 
factors are themselves considered as risk factors 
for DVT. Use of psychotropic drugs is one 
example that directly or indirectly paves the way 
for the disease. In study by Masoomi et al., the 
type of drug used by individuals was opium and 
heroin. In this study, considerable differences 
were found in the type of drug used and the 
incidence of DVT.16 Cornford et al. estimated the 
annual incidence of DVT to be 3.2% between 2005 
and 2009 which was more frequent among users 
of drugs like heroin and cocaine (4.8%).9 In a 
study in Glasgow, IDU was 21.4% prevalent 
among DVT patients. Mechanism of DVT 
incidence in these patients is probably related to 
repeated puncture in the femoral vein by injecting 
the drug leading to endothelial damage and 
releasing of tissue factors. Findings based on the 
levels of coagulation factors and inhibitors were 
not found in these groups. Increased levels of 
coagulation factors may play a role in the etiology 
of DVT.29 
Smoking which has a high prevalence among 
addicts is also a causing factor of DVT. Many 
studies have reported smoking as a risk factor for 
DVT,30 while in others, such a result is not 
stated.31 Thus, injectable drugs, especially 
narcotics, have an essential and important role in 
the incidence of DVT and should strongly be 
considered while at the present time, with the 
increasing prevalence of drug abuse in the society, 
the incidence of this complication is also likely to 
rise. This issue should be trained in the field of 
addiction prevention, and necessary training 
about the signs and symptoms of DVT and its 
prevention methods should be presented.  
Considering the prevalence of risk factors for 
DVT in the study population, high age was the 
most common risk factor in these patients. But 
how independent the age factor affects the disease 
requires a separate analytical study. Following the 
age factor, inactivity, and smoking were the most 
common risk factors so that 25% of patients had 
these two risk factors. Inactivity has been 
analyzed numerous studies and is a known risk 
factor for DVT and the pathophysiology of these 
factor is completely well known. In this study, the 
travel factor was seen as one of the risk factors for 
DVT. It was shown in a study that trips longer than 
10 h or more increase the risk of DVT for 0.6.32 
DVT is a complication which should be highly 
noticed for hospitalized patients, patients 
undergoing surgery, and patients who are 
inactive for a long time. In a study in Charleston, 
the highest incidence of DVT was associated with 
surgery risk factors33 and for such patients, 
anticoagulant medicines are used and with such 
contingencies, nowadays we are witnessing lower 
complication rates in hospitalized patients. 
Among the other prevalent factors, we can 
mention previous history of DVT and surgery and 
about 12% of patients had these risk factors. The 
impact of the previous history of DVT and 
surgical history are risk factors which have been 
mentioned in several studies and today, almost all 
hospitals highly pay attention to DVT, as one of 
the postoperative complications.8 Especially in 
orthopedic surgery patient in which a part of 
body may remain motionless for long, 
anticoagulant therapy is prescribed. 
Another risk factor which has covered nearly 
10% of patients in this study is a contraceptive 
drug which is highly prevalent in Iran. 
Nowadays, the use of contraceptive pills and 
hormone replacement therapy (HRT) treatments 
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are very common in Iran, and one of the few 
complications of these drugs is the risk of 
thrombosis which included approximately 10% of 
patients in this study. Some studies suggest a link 
between long-term use of these drugs and the risk 
of DVT. In a study, the risk of DVT by the use of 
contraceptive drugs is estimated to be 2.5 from 1 
to 5 years use, and 2.1 more than 5 years use.34  
Another major risk factors for DVT is cancer. 
In a study, the incidence rate of DVT in cancer 
patients was estimated to be 4-20%.35,36 As 
indicated previously, determining the 
independent role of each of these risk factors in 
thrombosis is very difficult and beyond the scope 
of this discussion because based on this results, 
about half of the patients had more than one risk 
factor for developing DVT, and thus determining 
the independent role of each of these factors is 
really difficult and requires several comparative 
studies. Based on the results, it can be inferred 
that many risk factors are involved in the 
incidence of DVT in our society and usually more 
than one risk factor contributes to create this 
complication. 
Another finding of the study which was one of 
the main aims of this study was the prevalence of 
drug addiction so that in more than 90% of 
patients, lower limbs were involved (including 
the right leg and left leg). The part of body having 
the most involvement was the left foot so that 
approximately 58% of patients had thrombosis in 
the left leg.  
Of course, associating one risk factor for 
thrombosis in such cases is very difficult and 
cannot be justified. However, in cases such as 
surgery and inactivity, the suffering location is 
surely in the injury spot. Another issue that was 
examined in this study was the incidence of DVT 
from 2005 to 2013. Though there was no 
significant difference between the incidence rate 
of the disease during the mentioned 8 years, but 
its incidence has increased about 2%. The 
prevalence of this complication among those 
hospitalized in St. Alzahra Hospital was 4 per 
each 1000 hospitalizations, but in 2013 it reached 
to 6.3 per each 1000 hospitalizations.  
This disorder rarely occurs in children < 15 
years old.37,38 Its prevalence increases with age 
and at the age of 56-69 years is 1.8% per 1000 
person and at the age of 85-89 years is 3.1% per 
thousand people.39 The rising trend of DVT can 
occur for many reasons. The first reason is in the 
prevalence of its risk factors that have increased in 
recent years such as long-term trips and air 
travels, increasing use of oral contraceptive pill 
(OCP), increasing the number of surgeries, etc.40 
Another noteworthy issue is the recognition of 
DVT cases which has become more and more 
accurate in recent years. In other words, by 
increasing the physicians’ ability to detect the 
disease and the arrival of new diagnostic devices 
many cases of this disease which would remain 
unknown in the past, are recognized today. Also, 
the emergence of a range of other risk factors, 
such as the treatment of HRT, the widespread use 
of contraception, etc. are also influential in 
increasing the incidence of DVT. 
Conclusion 
Drug use is a contributing factor in the 
incidence of DVT and should be considered: 
1. Drug addiction can boost the likelihood of 
getting the disease in several ways to and steps 
should be taken for its prevention among addicts, 
patients, and sedentary people 
2. Older age, long journeys, smoking, and 
surgeries are among the common risk factor for 
the incidence of DVT in these patients 
3. Over the past 8 years, DVT has had an 
increasing trend. 
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